Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment
Authors
Keywords
-
Journal
ESC Heart Failure
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-17
DOI
10.1002/ehf2.12960
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
- (2020) Jasper Fuk-Woo Chan et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
- (2020) Xintian Xu et al. Science China-Life Sciences
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
- (2020) Liang Chen et al. CARDIOVASCULAR RESEARCH
- COVID-19, Arrhythmic Risk and Inflammation: Mind the Gap!
- (2020) Pietro Enea Lazzerini et al. CIRCULATION
- Cardiovascular Toxicities Associated with Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database
- (2020) Lee S. Nguyen et al. CIRCULATION
- High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19
- (2020) Andrew R. Chapman et al. CIRCULATION
- COVID-19 and the Heart
- (2020) Akbarshakh Akhmerov et al. CIRCULATION RESEARCH
- Initial COVID-19 affecting cardiac patients in China
- (2020) Yaling Han EUROPEAN HEART JOURNAL
- Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy
- (2020) Riccardo M Inciardi et al. EUROPEAN HEART JOURNAL
- COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease
- (2020) Daniela Tomasoni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?
- (2020) Jixiang Zhang et al. HEART
- Cardiac and arrhythmic complications in patients with COVID‐19
- (2020) Adriano Nunes Kochi et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis
- (2020) Long‐quan Li et al. JOURNAL OF MEDICAL VIROLOGY
- Ramipril in High Risk Patients with COVID-19
- (2020) Ignacio J. Amat-Santos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
- (2020) Elissa Driggin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
- (2020) Francisco J de Abajo et al. LANCET
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19
- (2020) Mingyue Li et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- “Off-label” use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers
- (2020) Alexandre Gérard et al. THERAPIE
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
- (2020) Xin Zou et al. Frontiers of Medicine
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Tao Guo et al. JAMA Cardiology
- Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
- (2020) Shaobo Shi et al. JAMA Cardiology
- Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
- (2020) Jing Liu et al. EBioMedicine
- Speculation is not evidence: antihypertensive therapy and COVID-19
- (2020) Giovanni de Simone et al. European Heart Journal-Cardiovascular Pharmacotherapy
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
- (2018) Waleed H. Mahallawi et al. CYTOKINE
- ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection
- (2018) Susana Cadenas FREE RADICAL BIOLOGY AND MEDICINE
- Epidemiology of cardiovascular disease in China: current features and implications
- (2018) Dong Zhao et al. Nature Reviews Cardiology
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Molecular Evolution of Human Coronavirus Genomes
- (2017) Diego Forni et al. TRENDS IN MICROBIOLOGY
- Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis
- (2016) G. E. Callera et al. BIOSCIENCE REPORTS
- Targeting endoplasmic reticulum stress in hypoxia-induced cardiac injury
- (2016) William Durante VASCULAR PHARMACOLOGY
- The role of hypoxia in inflammatory disease (Review)
- (2015) JOHN BIDDLESTONE et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS
- (2013) Vaibhav B. Patel et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- TheACE2gene: its potential as a functional candidate for cardiovascular disease
- (2012) Louise M. Burrell et al. CLINICAL SCIENCE
- Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
- (2012) D. Caldeira et al. BMJ-British Medical Journal
- Role of curcumin on chloroquine phosphate-induced reproductive toxicity
- (2011) Ketaki R. Desai et al. DRUG AND CHEMICAL TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now